TATA Health International Holdings (01255) Announces February 2026 Monthly Equity Update
Bulletin Express
Yesterday
TATA Health International Holdings Limited (01255) reported that as of 28 February 2026, the authorized share capital remained at 500.00 million ordinary shares with a par value of HKD 0.01 per share, translating to a total authorized share capital of HKD 5.00 million. The number of issued shares stood at 242.85 million, with no treasury shares reported.
The update confirmed that the public float requirement has been maintained for the period under review, with no adjustments to the share structure during the month. The company did not disclose any additional changes or arrangements in relation to issued shares, securities, or convertible instruments for the stated period.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.